Three‐dimensional microtissues essentially contribute to preclinical validations of therapeutic targets in breast cancer-Reference-Cited by-同舟云学术

Three‐dimensional microtissues essentially contribute to preclinical validations of therapeutic targets in breast cancer

Published:2016-01-14 Issue:4 Volume:5 Page:703-710
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Falkenberg Natalie¹,Höfig Ines²,Rosemann Michael²,Szumielewski Justine¹,Richter Sabine²,Schorpp Kenji³,Hadian Kamyar³,Aubele Michaela¹,Atkinson Michael J.²⁴,Anastasov Nataša²

Affiliation:

1. Institute of Pathology Helmholtz Center Munich German Research Center for Environmental Health Ingolstaedter Landstrasse 1 85764 Neuherberg Germany

2. Institute of Radiation Biology Helmholtz Center Munich German Research Center for Environmental Health Ingolstaedter Landstrasse 1 85764 Neuherberg Germany

3. Assay Development and Screening Platform Institute of Molecular Toxicology and Pharmacology Helmholtz Center Munich German Research Center for Environmental Health Ingolstaedter Landstrasse 1 85764 Neuherberg Germany

4. Radiation Biology Technical University of Munich Ismaninger Strasse 22 81675 Munich Germany

Funder

Deutsche Forschungsgemeinschaft

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.630

Reference29 articles.

1. Biology's new dimension

2. Efficacy of anti-cancer agents in cell lines versus human primary tumour tissue